Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Join SI Premium – FREE
Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q4 EPS of $1.70, $0.12 better than the analyst estimate of $1.58. Revenue for the quarter came in at $107.1 million versus the consensus estimate of $106.16 million.
For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Waymo Explores Split With Uber - FT
- Jennifer Hyman to retire from Estee Lauder board in November
- Freedom Broker Downgrades Gentherm Incorporated (THRM) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
